Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: Safety run-in results of ANDROMEDA

MLA

Palladini, G.Kastritis, E.Maurer, M. S.Zonder, J.Minnema, M. C.Wechalekar, A. D.Jaccard, A.Lee, H. C.Bumma, N.Kaufman, J. L.Medvedova, E.Kovacsovics, T.Rosenzweig, M.Sanchorawala, V.Qin, X.Vasey, S. Y.Weiss, B. M.Vermeulen, J.Merlini, G.Comenzo, R. L. Daratumumab plus CyBorD for Patients with Newly Diagnosed AL Amyloidosis: Safety Run-in Results of ANDROMEDA. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..c5636f641409dd356bc71cd1aaa4309e&authtype=sso&custid=ns315887.

APA

Palladini, G. K. E. M. M. S. Z. J. M. M. C. W. A. D. J. A. L. H. C. B. N. K. J. L. M. E. K. T. R. M. S. V. Q. X. V. S. Y. W. B. M. V. J. M. G. C. R. L. (2020). Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: Safety run-in results of ANDROMEDA.

Chicago

Palladini, G. Kastritis, E. Maurer, M.S. Zonder, J. Minnema, M.C. Wechalekar, A.D. Jaccard, A. Lee, H.C. Bumma, N. Kaufman, J.L. Medvedova, E. Kovacsovics, T. Rosenzweig, M. Sanchorawala, V. Qin, X. Vasey, S.Y. Weiss, B.M. Vermeulen, J. Merlini, G. Comenzo, R.L. 2020. “Daratumumab plus CyBorD for Patients with Newly Diagnosed AL Amyloidosis: Safety Run-in Results of ANDROMEDA,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..c5636f641409dd356bc71cd1aaa4309e&authtype=sso&custid=ns315887.